In re Brand Name Prescription Drugs Antitrust Litigation

171 F.R.D. 213, 1997 WL 43034
CourtDistrict Court, N.D. Illinois
DecidedJanuary 27, 1997
DocketNos. 94 C 897, MDL 997
StatusPublished
Cited by7 cases

This text of 171 F.R.D. 213 (In re Brand Name Prescription Drugs Antitrust Litigation) is published on Counsel Stack Legal Research, covering District Court, N.D. Illinois primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Brand Name Prescription Drugs Antitrust Litigation, 171 F.R.D. 213, 1997 WL 43034 (N.D. Ill. 1997).

Opinion

MEMORANDUM OPINION

KOCORAS, District Judge:

This case comes before the court on one plaintiffs motion to confirm its status as a [214]*214non-class plaintiff or, in the alternative, for an enlargement of time to deliver its election to opt out of the class. For the reasons discussed below, the former motion is granted, and the latter motion is deemed moot.

BACKGROUND

The factual background of this multidis-triet litigation is well-covered in the prior decisions of this court. In short, a number of actions have been filed by plaintiffs alleging, inter alia, a conspiracy among prescription brand name drug manufacturers to fix prices for such drugs and price discrimination through their use of a “two-tiered” pricing system. The Judicial Panel on Multidistrict Litigation has referred the cases arising from this pricing system to this court for pre-trial proceedings.

On November 15, 1994, this court certified a class consisting mainly of retail pharmacists that had purchased prescription brand name drugs directly from any of the defendants. On January 12, 1995, this court entered an Order authorizing the mailing and publication of Notice of the Pendency of Class Action (hereinafter “the Notice”). The Notice described the issues relating to the class action and informed class members that they had until March 10, 1995 to opt out of the action. The notiee included a section that read as follows:

IV. HOW TO BE EXCLUDED FROM THE CLASS
You may be excluded from the Class only upon specific written request, provided your request is delivered on or before March 10, 1995 to In Re Brand Name Prescription Drugs Antitrust Litigation, P.O. Box No. 837, Chicago, Illinois 60690-0837. The request for exclusion must clearly state your name and address and that you wish to be excluded from the Class. You need not state the reason for this request.
If you request exclusion, you will not be entitled to share in the benefits of any settlement or other recovery obtained in these actions and will not be bound by any judgment.

The notiee also stated: “The pleadings and other records in this litigation may be examined and copied at any time during the regular office hours at the Clerk of the Court, 219 S. Dearborn St., 20th Floor, Chicago, Illinois 60604”

Randall’s Food & Drugs, Inc. (“Randall’s”) is a Texas grocery chain which operates approximately 110 pharmacies in its stores. Given its home state, it is not surprising that Randall’s describes itself as, and indeed is, “large.” In early 1994, it became aware of some of the suits against drug manufacturers. On August 18, 1994, Randall’s filed a complaint against 23 manufacturers in the Southern District of Texas. At Randall’s request, this lawsuit — referred to by Randall’s as the “First Lawsuit” — was consolidated into this MDL action in September, 1994. Randall’s received the Notice, and decided that it did not want to participate in the class action. Thus, Randall’s opted to attempt to follow the procedures for opting out of the class. However, the opt-out notice was not ready to be sent until March 9,1995, the day before the deadline included in the Notice. In order to ensure that the election was timely received, Randall’s decided to ship the election via Federal Express. There was one problem: Federal Express will not deliver to a P.O. Box. Because the Notice listed the clerk of this court as the place at which records could be examined, Randall’s counsel assumed that the P.O. Box given as the address was also for the Clerk of the Court. Therefore, he gave the address of the Clerk of the Court to Federal Express, which did deliver the election to the Clerk on March 10.

On March 31, 1995, Randall’s filed a second action — one it calls the Second Lawsuit — in the Southern District of Texas against the same 23 manufacturer-defendants as the First Lawsuit. The Second Lawsuit added four defendants and a number of additional claims. Randall’s subsequently joined a large group of opt-out plaintiffs, called the “Duker Boies” plaintiffs, who were pursuing their claims against the 23 defendants. In August, 1996, a litigation support group working for the Duker Boies group prepared a list of chain stores with pharmacies, and noticed that Randall’s .was not on the opt-out list. In October, Randall’s coun[215]*215sel was informed of this, realized that it had not properly opted out, and filed this motion. Randall’s seeks confirmation that it opted out of the class, or, in the alternative, an enlargement of time to properly deliver its election to opt out.

DISCUSSION

Randall’s makes two separate motions in the alternative. First, it seeks confirmation that it has opted out of the class. If we find that it has not opted out of the class, Randall seeks an enlargement of the time in which it may file its Election to opt out. Defendants Manufacturers’ position is that (1) Randall’s has conceded that it has not yet opted out, and (2) it should not be granted an enlargement of time. We examine these motions separately.

I. Motion to Confirm Its Opt-Out Status

Randall’s first moves for a confirmation that it has opted out of the class, pursuant to Fed.R.Civ.P. 23(b)(2)(A). Rule 23(b)(2)(A) provides that the notice to each potential class member should include notice that “the court will exclude the member from the class if the member so requests by a specified date----” The purpose of the rule requiring prompt notice of exclusion is to prevent parties from waiting to see if the adjudication in the .class action is favorable before deciding whether to join the class. In re Four Seasons Sec. Law Litigation, 493 F.2d 1288, 1291 (10th Cir.1974). The parties agree that the relevant “specified date” is March 10, 1995. This is the date which the Notice to Class Members included as the deadline by which members opting out of the class had to file notice of that decision. The question then is whether Randall’s actions prior to March 10, 1995 were sufficient to signify a desire to be excluded from the class.

The standard for determining whether a party’s actions constitute an election to opt out is not entirely clear. Wright & Miller argue that “considerable flexibility is desirable in determining what constitutes an effective expression of a class member’s desire to exclude himself----” 7B Charles Alan Wright, Arthur R. Miller & Mary Kay Kane, Federal Practice and Procedure § 1787 (1986). The Tenth Circuit has adopted this approach, requiring only “[a] reasonable indication of a desire to opt out ...and adopting Wright & Miller’s preference for “flexibility in determining what constitutes an expression of a desire to opt out.” In re Four Seasons, 493 F.2d at 1291 (quoting Wright, Miller & Kane). A number of other courts have adopted this preference for “considerable flexibility” and thus require only a “reasonable indication” of a desire to opt out! See, e.g., Plummer v. Chemical Bank, 668 F.2d 654, 657 n. 2 (2d Cir.1982); Council on Social Work Education, Inc. v. Texas Instruments Inc., 105 F.R.D. 68, 71 (N.D.Tex. 1985) (citing 2 Newberg, Class Actions § 2475r (1977)). The Seventh Circuit has also commented favorably on the rule set forth in Four Seasons.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Kraft Foods Global, Inc. v. Cal-Maine Foods, Inc.
130 F. Supp. 3d 945 (E.D. Pennsylvania, 2015)
Currie v. WISCONSIN CENT., LTD.
2011 IL App (1st) 103095 (Appellate Court of Illinois, 2011)
Currie v. Wisconsin Central
2011 IL App (1st) 103095 (Appellate Court of Illinois, 2011)
Demint v. Nationsbank Corp.
208 F.R.D. 639 (M.D. Florida, 2002)

Cite This Page — Counsel Stack

Bluebook (online)
171 F.R.D. 213, 1997 WL 43034, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-brand-name-prescription-drugs-antitrust-litigation-ilnd-1997.